Journal
CLINICAL INFECTIOUS DISEASES
Volume 64, Issue 3, Pages 361-363Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw743
Keywords
ESBL; carriage; proton pump inhibitor; risk factor
Categories
Ask authors/readers for more resources
In this cross-sectional study, 8.5% of patients using proton pump inhibitors (PPIs) were rectal carriers of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), compared with 2.9% of non-PPI users. In multivariable analysis, PPI use was independently associated with ESBL-E rectal carriage at hospital admission (adjusted odds ratio, 3.89; 95% confidence interval, 1.65 - 9.19).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available